Debt-to-equity of CytoDyn Inc. from 29 Feb 2012 to 30 Nov 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CytoDyn Inc. quarterly Debt-to-equity in % history and change rate from 29 Feb 2012 to 30 Nov 2025.
  • CytoDyn Inc. Debt-to-equity for the quarter ending 30 Nov 2025 was -115%, a 2.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CytoDyn Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 -115% +3% +2.5% 30 Nov 2025
Q3 2025 -121% -7.1% -6.2% 31 Aug 2025
Q2 2025 -125% -16% -15% 31 May 2025
Q1 2025 -122% -13% -12% 28 Feb 2025
Q4 2024 -118% -7.5% -6.7% 30 Nov 2024
Q3 2024 -113% -3.4% -3% 31 Aug 2024
Q2 2024 -109% +5.2% +4.5% 31 May 2024
Q1 2024 -109% +9.9% +8.3% 29 Feb 2024
Q4 2023 -111% +38% +26% 30 Nov 2023
Q3 2023 -110% +104% +49% 31 Aug 2023
Q2 2023 -114% +200% +64% 31 May 2023
Q1 2023 -119% +515% +81% 28 Feb 2023
Q4 2022 -149% +560% +79% 30 Nov 2022
Q3 2022 -214% +607% +74% 31 Aug 2022
Q2 2022 -314% +975% +76% 31 May 2022
Q1 2022 -634% +1286% +67% 28 Feb 2022
Q4 2021 -708% +2463% +78% 30 Nov 2021
Q3 2021 -821% +410% +33% 31 Aug 2021
Q2 2021 -1290% -730% -130% 31 May 2021
Q1 2021 -1921% -1536% -399% 28 Feb 2021
Q4 2020 -3171% -2853% -897% 30 Nov 2020
Q3 2020 -1232% -865% -236% 31 Aug 2020
Q2 2020 -560% -296% -112% 31 May 2020
Q1 2020 -385% -169% -78% 29 Feb 2020
Q4 2019 -318% -130% -70% 30 Nov 2019
Q3 2019 -367% -213% -138% 31 Aug 2019
Q2 2019 -264% -103% -64% 31 May 2019
Q1 2019 -216% -19% -9.5% 28 Feb 2019
Q4 2018 -188% +123% +40% 30 Nov 2018
Q3 2018 -154% -3402% -105% 31 Aug 2018
Q2 2018 -162% -361% -181% 31 May 2018
Q1 2018 -197% -293% -304% 28 Feb 2018
Q4 2017 -310% -372% -605% 30 Nov 2017
Q3 2017 3248% +3171% +4107% 31 Aug 2017
Q2 2017 200% -43% -18% 31 May 2017
Q1 2017 96% +555% 28 Feb 2017
Q4 2016 61% +254% 30 Nov 2016
Q3 2016 77% +270% 31 Aug 2016
Q2 2016 243% +476% 31 May 2016
Q1 2016 -459% +2744% +86% 29 Feb 2016
Q4 2015 -193% -410% -189% 30 Nov 2015
Q3 2015 -193% -278% -326% 31 Aug 2015
Q2 2015 -234% -324% -360% 31 May 2015
Q1 2015 -3203% -3316% -2933% 28 Feb 2015
Q4 2014 217% +11% +5.1% 30 Nov 2014
Q3 2014 85% +3556% 31 Aug 2014
Q2 2014 90% +494% 31 May 2014
Q1 2014 113% +350% 28 Feb 2014
Q4 2013 207% +397% 30 Nov 2013
Q3 2013 -3471% -3340% -2550% 31 Aug 2013
Q2 2013 -404% -271% -205% 31 May 2013
Q1 2013 -237% -102% -75% 28 Feb 2013
Q4 2012 -191% 30 Nov 2012
Q3 2012 -131% 31 Aug 2012
Q2 2012 -132% 31 May 2012
Q1 2012 -135% 29 Feb 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.